Hirano T. Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine. International Immunopharmacol 2007, 7: 3-22
Kurata Y, M Kato, T Kuzuya, Y Miwa, K Iwasaki, M Haneda. Pretransplant Pharmacodynamic Analysis of Immunosuppressive agents using CFSE based T cell proliferation assay. Clinical Pharmacology & Therapeutics 2009; 86 (3): 285-289
Gulimire Muhetaer, Hironori Takeuchi, Sakae Unezaki, Shigeyuki Kawachi, Hitoshi Iwamoto, Yuki Nakamura et al. Clinical Significance of Peripheral Blood Lymphocyte Sensitivity to Glucocorticoids for the Differentiation of High-risk Patients With Decreased Allograft Function After Glucocorticoid Withdrawal in Renal Transplantation. Clinical Therapeutic 2014;36 (8): 1264-1272
Francis DM, Dumble LJ, Bowes L, Clunie GJ, Macdonald IM. Adverse influence of recipient lymphoid resistance to in vitro immunosuppression on the outcome of kidney transplants. Transplantation. 1988 Dec;46(6):853-7.
Aurelie Premaud, Matthieu Filloux, Philippe Gatault , Antoine Thierry , Matthias Büchler, Eliza Munteanu et al. An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies. PLoS ONE 2017. 12(7): e0180236. https://doi. org/10.1371/journal.pone.0180236
Madhav C. Menon, Barbara Murphy, and Peter S. Heeger. Moving Biomarkers toward Clinical Implementation in Kidney Transplantation. J Am Soc Nephrol 2017 28: 735–747
